bristol myers squibb co
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for bristol myers squibb co from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 46 transactions, with a transaction quantity of 897.48 and a transaction weight of 1120.04.
- Year Transactions Quantity Weight
- 2025 209 5208.94 3516.96
- 2026 46 897.48 1120.04
Bill of lading data
< 1/15 >- Trade date 2026/06/30 B/L No. 107955
- Suppliers bristol myers squibb co Buyers bristol myers squibb peru s.a.
- POLs new york-john f. kennedy apt PODs aérea del callao
- Supply area United States Purchas area Peru
- Weight 48.217kg Amount 208959.88
- Hs code 3006930000 Product tags ——
- Product description MEDICAMENTO, S/M, S/M KIT PARA ENSAYOS CLINICOS DOBLE CIEGO SEGUN PROTOCOLO N° IM027-1015. RD:112-2025--DIIS/INS ESTUDIO FASE 3, MULTICENTRICO, ALEATORIZADO, DOBLE CIEGO PARA TRATAMIENTO DE FIBROSIS PULM ADE0476 BMS-986278 TAB 60MG CTD PLACEBO. LOTE:ADE4880, VCTO:30/09/2029. BMS-986278 TAB 60M BMS-986278 TAB 60MG/PBO (1PK) IM027DBMUL. LOTE:ADJ0743, VCTO:31/03/2030 Expand
- Trade date 2026/05/04 B/L No. 072228
- Suppliers bristol myers squibb co Buyers bristol myers squibb peru s.a.
- POLs o hare international (chicago PODs aérea del callao
- Supply area United States Purchas area Peru
- Weight 2.268kg Amount 1778.48
- Hs code 3006930000 Product tags ——
- Product description MEDICAMENTO, S/M, S/M KIT PARA ENSAYOS CLINICOS DOBLE CIEGO, DEUCRAVACITINIB 3MG/6MG. PROTOCOLO N° IM0111069 ESTUDIO FASE 3 ALEATORIZADO, DOBLE CIEGO. RD:18512-205/DIGEMID, RD:N°000397-2025-INS/DIIS PARA TRATAMIENTO EN ADULTOS CON SINDROME DE SJOGREN ACTIVO BMS986165TAB/PLB (1BLCRX64)IM011DBMUL. LOTE:ADG9904, VCTO:08/2027. PLACEBO, MSVC Expand
- Trade date 2026/04/30 B/L No. 070779
- Suppliers bristol myers squibb co Buyers bristol myers squibb peru s.a.
- POLs o hare international (chicago PODs aérea del callao
- Supply area Switzerland Purchas area Peru
- Weight 9.526kg Amount 188134.6
- Hs code 3002151000 Product tags perjeta,pembrolizumab
- Product description MEDICAMENTO, OPDUALAG, S/M NIVOLUMAB 240MG Y RELATLIMAB 80MG // RS:BE-01423 - RD:18615-2024-DIGEMID DEL 05/12/2024. F TRATAMIENTO DE UNA ENFERMEDAD ONCOLOGICA PARA EL TRATAMIENTO DE PACIENTES ADULTOS Y PEDIAT CAJA CONTENIDO 1 VIAL DE VIDRIO TIPO I INCOLORO CON SELLO FLIP-OFF DE ALUMINIO CON TAPA AM COD:1445662. OPDUALAG 240MG/80MG (1VLX20ML) PE. LOTE:005D25A, VCTO:04/2028 Expand
- Trade date 2026/04/17 B/L No. 91003049970745
- Suppliers bristol myers squibb co Buyers bristol myers squibb de col s.a.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 3.06kg Amount 666
- Hs code 9025191900 Product tags thermometers,pyrometers
- Product description DO 260203-001 CODIGO / RESOLUCION OEA IMPORTADOR: RESOLUCION 002109 DE MARZO 21 DE 2019 DECLARACION(1-1) MERCANCIA NUEV Expand
- Trade date 2026/04/17 B/L No. 91003049969341
- Suppliers bristol myers squibb co Buyers bristol myers squibb de col s.a.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 3.06kg Amount 1402.2
- Hs code 9025191900 Product tags thermometers,pyrometers
- Product description DO 260204-001 CODIGO / RESOLUCION OEA IMPORTADOR: RESOLUCION 002109 DE MARZO 21 DE 2019 DECLARACION(1-1) MERCANCIA NUEV Expand
- Trade date 2026/04/10 B/L No. 057514
- Suppliers bristol myers squibb co Buyers bristol myers squibb peru s.a.
- POLs montevideo PODs aérea del callao
- Supply area Switzerland Purchas area Peru
- Weight 2.55kg Amount 99795.048
- Hs code 3004902400 Product tags oncological,atazanavir
- Product description MEDICAMENTO, REVLIMID, S/M LENALIDOMIDA. ELABORADO POR CELGENE INTERNATIONAL SARL-SUIZA MEDICAMENTO ONCOLOGICO PARA USO HUMANO CAJA X 21 CAPSULAS // RS:EE-05110 - RD:16742-2024/DIGEMID DEL 11/11/2024 COD:1428382. REVLIMID CAP 15MG (3BLPX7) PE. LOTE:ADF2175AD, VCTO:03/2027 Expand
- Trade date 2026/04/07 B/L No. 055491
- Suppliers bristol myers squibb co Buyers bristol myers squibb peru s.a.
- POLs montevideo PODs aérea del callao
- Supply area Switzerland Purchas area Peru
- Weight 2.79kg Amount 241382.035
- Hs code 3004902400 Product tags oncological,atazanavir
- Product description MEDICAMENTO, REVLIMID, S/M LENALIDOMIDA. ELABORADO POR CELGENE INTERNATIONAL SARL-SUIZA MEDICAMENTO ONCOLOGICO PARA USO HUMANO CAJA x 21 CAPSULAS // RS:EE-03623 - RD:16741-2024/DIGEMID DEL 11/11/2024 COD:1428414. REVLIMID CAP 10MG (3BLPx7) PE. LOTE:ADF2091AJ, VCTO:03/2027 Expand
- Trade date 2026/04/06 B/L No. 91003049765588
- Suppliers bristol myers squibb co Buyers bristol myers squibb de col s.a.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 4.28kg Amount 120
- Hs code 3004902400 Product tags equipped with fixed dose drug
- Product description DO BC7O0000777-001 DECLARACION(1-1) PRESENTAMOS REG-50054431-20260319N FECHA APROBACION2026-03-18 FECHA VIGENCIA 2026-09 Expand
- Trade date 2026/04/06 B/L No. 91003049766318
- Suppliers bristol myers squibb co Buyers bristol myers squibb de col s.a.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 1.36kg Amount 29148
- Hs code 3004902400 Product tags equipped with fixed dose drug
- Product description DO BC7O0000779-001 DECLARACION(1-1) NUMERO VISTO BUENO: VINVIMA-26-0039159 CON FECHA 2026-03-18 . FACTURA: 45692729 FE Expand
- Trade date 2026/03/31 B/L No. 91003049712559
- Suppliers bristol myers squibb co Buyers bristol myers squibb de col s.a.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 1.44kg Amount 310.8
- Hs code 9025191900 Product tags thermometers,pyrometers
- Product description DO 260159-001 CODIGO RESOLUCION OEA IMPORTADOR: RESOLUCION 002109 DE MARZO 21 DE 2019 DECLARACION(1-1) MERCANCIA NUEV Expand
- Trade date 2026/03/31 B/L No. 052039
- Suppliers bristol myers squibb co Buyers bristol myers squibb peru s.a.
- POLs o hare international (chicago PODs aérea del callao
- Supply area United States Purchas area Peru
- Weight 7.257kg Amount 2993.6
- Hs code 3006930000 Product tags ——
- Product description MEDICAMENTO, S/M, S/M KIT PARA ENSAYOS CLINICOS DOBLE CIEGO, DEUCRAVACITINIB 3MG/6MG. PROTOCOLO N° IM0111069 ESTUDIO FASE 3 ALEATORIZADO, DOBLE CIEGO. RD:18512-205/DIGEMID, RD:N°000397-2025-INS/DIIS PARA TRATAMIENTO EN ADULTOS CON SINDROME DE SJOGREN ACTIVO BMS986165TAB/PLB (1BLCRX64)IM011DBMUL. LOTE:ADF1578, VCTO:08/2027. PLACEBO, MSVC Expand
- Trade date 2026/03/26 B/L No. 92003006642153
- Suppliers bristol myers squibb co Buyers bristol myers squibb de col s.a.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 2.28kg Amount 297176
- Hs code 3002151000 Product tags immunological products
- Product description DO BC7O0000778-001 DECLARACION(1-1) PRESENTAMOS LIC-40006557-20260318N FECHA APROBACION 2026-03-18 VENCIMIENTO 2026-09-17// NUMERO VISTO BUENO VINVIMA-26-0038803 FECHA APROBACION 2026-03-18 // EXENTA IVA (ESTATUTO TRIBUTARIO)DECRETO EXTRAORDINARIO 624 DE 1989, MINISTERIO DE HACIENDA Y CREDITO PUBLICO ARTICULO 477. FACTURA: 45683737 FECHA: 2026-03-04 PRODUCTO: NIVOLUMAB /RELATLIMAB (BMS986213), ORIGEN: BIOLOGICO, ASPECTO FISICO: LIQUIDO CLARO A OPALESCENTE, INCOLORO A AMARILLO PALIDO. PUEDE CONTENER (POCAS) PARTICULAS, TIPO DE EMPAQUE: VIALES DE NIVOLUMAB 480 MG / RELATLIMAB 480 MG (CAJA X 1 VIAL), USO: HUMANO - ONCOLOGICO, MARCA: NO TIENE,, NO 1045453, 1045454, 1045455, 1045456, 1045457, 1045458, 1045459, 1045460, 1045461, 1045462, 1045463, 1045464, 1045465, 1045466, 1045467, 1045468, 1045469, 1045470, 1045471, 1045472, 1045473, 1045474, 1045475, 1045476, 1045477, 1045478, 1045479, 1045480, 1045481, 1045482, 1045483, 1045484, 1045485, 1045486, 1045487, 1045488, 1045489, 1045490, 1045491, 1045492, 1045493, 10 Expand
- Trade date 2026/03/20 B/L No. 045373
- Suppliers bristol myers squibb co Buyers bristol myers squibb peru s.a.
- POLs montevideo PODs aérea del callao
- Supply area Switzerland Purchas area Peru
- Weight 3.03kg Amount 198020.234
- Hs code 3004902400 Product tags oncological,atazanavir
- Product description MEDICAMENTO, REVLIMID, S/M LENALIDOMIDA. ELABORADO POR CELGENE INTERNATIONAL SARL-SUIZA MEDICAMENTO ONCOLOGICO PARA USO HUMANO CAJA x 21 CAPSULAS // RS:EE-03565 - RD:16744-2024/DIGEMID DEL 11/11/2024 COD:1428435. REVLIMID CAP 5MG (3BLPx7) PE. LOTE:ADF0112AB, VCTO:08/2027 Expand
- Trade date 2026/03/12 B/L No. 91003049462435
- Suppliers bristol myers squibb co Buyers bristol myers squibb de col s.a.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 29.48kg Amount 261222
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO BC7O0000755-001 DECLARACION(1-1) PRESENTAMOS LIC-40003965-20260219N FECHA APROBACION 2026-02-19 VENCIMIENTO 2026-08-18 // VINVIMA-26-0024031 FECHA 2026-02-18 // EXENTA IVA (ESTATUTO TRIBUTARIO) DECRETO EXTRAORDINARIO 624 DE 1989, MINISTERIO DE HACIENDAY CREDITO PUBLICO ARTICULO 477 //. FACTURA: 45595496 FECHA: 2026-02-10 PRODUCTO: DEUCRAVACITINIB (BMS-986165), NOMBRE COMERCIAL: DEUCRAVACITINIB, PRINCIPIO ACTIVO: DEUCRAVACITINIB (BMS-986165), CONCENTRACION: 3MG, INDICACIONES TERAPEUTICAS: LUPUS ERITEMATOSO, FORMA FARMACEUTICA: TABLETAS, TIPO DE EMPAQUE: FRASCO POR 68 TABLETAS, USO: HUMANO / REUMATOLOGIA, MARCA: NO TIENE,, SERIAL: 960824, 960825, 960826, 960827, 960828, 960829, 960830, 960831, 960832, 960833, 960834, 960835, 960836, 960837, 960838, 960839, 960840, 960841, 960842, 960843, 960844, 960845, 960846, 960847, 960848, 960849, 960850, 960851, 960852, 960853, 960854, 960855, 960856, 960857, 960858, 960859, 960860, 960861, 960862, 960863, 960864, 960865, 960866, 960867, 960868, 960869, 960870, 960871, Expand
- Trade date 2026/03/06 B/L No. 92003006050599
- Suppliers bristol myers squibb co Buyers bristol myers squibb de col s.a.
- POLs —— PODs bogota
- Supply area United States Purchas area Colombia
- Weight 1.34kg Amount 51
- Hs code 3004902400 Product tags equipped with fixed dose drug
- Product description DO BC7O0000751-001 DECLARACION(2-2) PRESENTAMOS REG-50033645-20260219N FECHA APROBACION 2026-02-19 VENCIMIENTO 2026-08-19 // VINVIMA-VINVIMA-26-0024127 FECHA 2026-02-19 // EXENTA IVA (ESTATUTO TRIBUTARIO) DECRETO EXTRAORDINARIO 624 DE 1989, MINISTERIO DEHACIENDA Y CREDITO PUBLICO ARTICULO 477. FACTURA: 45593233 FECHA: 2026-01-08 PRODUCTO: BMS-986348 CAP 0.2MG, NOMBRE COMERCIAL: NO TIENE, PRINCIPIO ACTIVO: CC-92480 (BMS-986348) /MEZIGDOMIDA, CONCENTRACION: 0.2 MG, INDICACIONES TERAPEUTICAS: CANCER - MIELOMA MULTIPLE RECIDIVANTE O REFRACTARIO, FORMA FARMACEUTICA: CAPSULA, TIPO DE EMPAQUE: BOTELLA POR 21 CAPSULAS, USO: HUMANO - HEMATOONCOLOGIA, MARCA: NO TIENE,, SERIALES 1336840 1336841 1336842 1336843 1336844 1336845 1336846 1336847 1336848 1336849 13368501336851 1336852 1336853 1336854 1336855 1336856 1336857 1336858 1336859 1336860 1336861 1336862 1336863 1336864 1336865 1336866 1336867 1336868 1336869 1336870 1336871, DESCRIPCION SEGUN FACTURA: PRODUCT DESCRIPTION BMS-986348CAP0.2MG(1BTLX21)CA057OLMULP4, LO Expand
Partners
Total 162- Rank Company Transactions Per Detail
- 1 ооо бристол майерс сквибб russiabuyer,they trade on 2019-07-19 1728 26.66% >
- 2 bristol myers squibb argentina s.r.l. argentinabuyer,they trade on 2023-04-10 773 11.93% >
- 3 bristol myers squibb peru s.a. perusupplier,they trade on 2026-06-30 549 8.47% >
- 4 bristol myers squibb co united statessupplier,they trade on 2023-01-05 371 5.72% >
- 5 bristol myers souibb de colombia s.a. colombiabuyer,they trade on 2015-07-28 261 4.03% > +View All
Products
Total 77- Products Transactions Per Detail
-
perjeta
19 13.19% > -
pembrolizumab
19 13.19% > -
dose
12 8.33% > -
measure
12 8.33% > -
oncological
11 7.64% >
+View All
Hscode rank
Total 276- HSCode Name Transactions Per Detail
- HS 30049000 23 15.97% >
- HS 3002151000 20 13.89% >
- HS 3004902400 16 11.11% >
- HS 30043200 15 10.42% >
- HS 3006930000 14 9.72% > +View All
Trading Area
Total 30- Area Transactions Per Detail
- russia 1869 28.84% >
- united states 1366 21.08% >
- colombia 700 10.80% >
- peru 645 9.95% >
- argentina 394 6.08% > +View All
Port statistics
Total 60- Port Name Transactions Per Detail
- leghorn 554 8.55% >
- san juan pr 501 7.73% >
- naples 211 3.26% >
- new york ny 125 1.93% >
- usjfk 104 1.60% > +View All
bristol myers squibb co is united states Buyer&Supplier,
and primarily engages in the import and export business of products such as perjeta，pembrolizumab，dose.
According to the 52wmb.com global trade database, as of 2026-06-30, the company has completed 6481 international trades,
with its main trading regions covering russia，united states,colombia etc.
The core products include HS30049000，HS3002151000，HS3004902400 etc,
often transported via leghorn，port san juan pr, port naples etc,
and its main trading partners are ооо бристол майерс сквибб，bristol myers squibb argentina s.r.l.，bristol myers squibb peru s.a..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on bristol myers squibb co is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool